Filter
760
Filtered Results: 760
Text search:
Emergency
Use
Authorization
Featured
Recommendations
89
New Publications
161
Language
Document type
No document type
296
Guidelines
195
Studies & Reports
134
Manuals
49
Strategic & Response Plan
34
Fact sheets
27
Training Material
15
Situation Updates
6
Resource Platforms
2
Brochures
1
Videos
1
Countries / Regions
Global
28
Kenya
26
India
22
South Africa
21
Western and Central Europe
20
Myanmar / Burma
18
Latin America and the Carribbean
15
Ghana
13
Sierra Leone
13
Nigeria
13
Africa
12
Liberia
11
Rwanda
10
Syria
10
Germany
10
Congo, Democratic Republic of
10
Nepal
9
Eastern Europe and Central Asia
9
East and Southern Africa
9
Cameroon
8
Haiti
8
West and Central Africa
8
Bangladesh
8
Uganda
8
Russia
8
Malawi
7
South Sudan
7
Zimbabwe
6
Venezuela
6
Middle East and North Africa
6
Brazil
6
Namibia
6
Ethiopia
6
Ecuador
6
Senegal
5
Guinea
5
Tanzania
5
Central African Republic
5
Eswatini/ Swaziland
5
Ukraine
4
Eastern Europe
4
Yemen
4
Mali
4
Zambia
4
Colombia
3
Thailand
3
Lesotho
3
Afghanistan
3
Peru
3
Philippines
3
Mozambique
3
Cambodia
3
Côte d’Ivoire / Ivory Coast
3
Chad
3
Pakistan
3
El Salvador
2
Benin
2
Gambia
2
Kazakhstan
2
Chile
2
Laos
2
Niger
2
Burkina Faso
2
Asia
2
Jordan
2
South–East Asia Region
2
Paraguay
2
Spain
2
Bolivia
2
Libya
2
Indonesia
2
Iraq
2
North Macedonia
1
Tajikistan
1
Mexico
1
Serbia
1
Togo
1
Albania
1
Kyrgyzstan
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Morocco
1
Qatar
1
Mauritania
1
Armenia
1
USA
1
Dominican Republic
1
Saudi Arabia
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Belarus
1
Israel
1
Argentina
1
Lebanon
1
Vietnam
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Egypt
1
Sudan
1
Palestine
1
Georgia
1
Honduras
1
Angola
1
Bhutan
1
Somalia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
275
Key Resources
64
Clinical Guidelines
48
Women & Child Health
30
Public Health
26
Pharmacy & Technologies
18
Capacity Building
4
Toolboxes
COVID-19
190
AMR
53
Pharmacy
31
HIV
30
Rapid Response
29
Conflict
28
Ebola & Marburg
25
Refugee
22
Mental Health
16
TB
15
Caregiver
14
Planetary Health
14
Natural Hazards
13
2.0 Rapid Response
12
Malaria
11
Specific Hazards
8
NTDs
7
NCDs
7
Health Financing Toolbox
6
Zika
6
Global Health Education
6
Disability
4
Cholera
4
Polio
2
Social Ethics
1
Typhoon
1
Transformation and outlook
Journal des anthropologues n° 138-139, 2014
http://journals.openedition.org/jda/4444
Le médicament pharmaceutique industriel est un objet de santé
à la fois scientifique, populaire et marchand. Si ces deux premiers
caractères sont souvent mis en avant respectivement par les sciences
biom...
La thèse de Yobouet Inès Kouakou, soutenue à l’Université Claude Bernard Lyon 1, porte sur le traitement d’urgence du paludisme sévère chez l’enfant à l’aide d’une administration intranasale d’artésunate. L’objectif principal de ce travail est d’explorer, in vitro, la voie na...
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac...
The number of confirmed COVID-19 cases detected and reported in each country is influenced by
many factors including limited access and/or utilization of healthcare and COVID-19 testing, limited
surveillance, lack of knowledge amongst the population about when to seek testing, an asymptomatic pres...
10 December 2020
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
Mobile vaccination teams visiting long-term care homes will have an important role in providing vaccination coverage for some of the most vulnerable population sub-groups. However, based on the experiences of German mobile diagnostic teams during the first COVID-19 pandemic w...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect ...
El presente protocolo se aplica en las Instituciones Prestadoras de Servicios de Salud del Ministerio de Salud, a través de las Direcciones de Redes Integradas de Servicios de Salud y de los gobiernos regionales, a través de las Direcciones Regionales de Salud o Gerencias Regionales de Salud , EsS...
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them will make, who they trust, their perceptions of risk,...
During the reporting period, significant progress was made in strengthening the mpox response across the continent. The lessons learned and challenges identified during the joint mpox continental intra-action review (IAR), which took place successfully in December 2024 in Addis Ababa have guided the...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
